These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 29528587)

  • 1. CD81 and CD19 as Marker of Activity in Systemic Lupus Erythematosus Disease.
    Abu-Zahab Z; Gad NM; Sabry S; Nassib SA
    Egypt J Immunol; 2017 Jun; 24(2):141-149. PubMed ID: 29528587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of costimulatory molecules on peripheral blood lymphocytes of patients with systemic lupus erythematosus.
    Bijl M; Horst G; Limburg PC; Kallenberg CG
    Ann Rheum Dis; 2001 May; 60(5):523-6. PubMed ID: 11302879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD19/22 balance relates to improvement of disease activity in systemic lupus erythematosus.
    Suzuki J; Nakano S; Nakairi Y; Mitsuo A; Amano H; Morimoto S; Tokano Y; Takasaki Y
    Mod Rheumatol; 2006; 16(4):235-8. PubMed ID: 16906374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD38, CD81 and BAFFR combined expression by transitional B cells distinguishes active from inactive systemic lupus erythematosus.
    Henriques A; Silva I; Inês L; Souto-Carneiro MM; Pais ML; Trindade H; da Silva JA; Paiva A
    Clin Exp Med; 2016 May; 16(2):227-32. PubMed ID: 25894569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients with systemic lupus erythematosus show increased proportions of CD19
    Zhu Q; Li Y; Zhang L; Wang M; Chen Z; Shi J; Li J; Li B; Li Z; Wang Y; Xie C
    Clin Rheumatol; 2021 Jan; 40(1):151-165. PubMed ID: 32542581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential role of Ets-1 and miR-326 in CD19
    Jin L; Fang X; Dai C; Xiang N; Tao J; Sun X; Azmi F; Cao Q; Li X; Wang Y; Li X
    Clin Rheumatol; 2019 Apr; 38(4):1031-1038. PubMed ID: 30456527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD19
    Xiong H; Tang Z; Xu Y; Shi Z; Guo Z; Liu X; Tan G; Ai X; Guo Q
    Adv Rheumatol; 2022 Dec; 62(1):48. PubMed ID: 36494762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated CD19
    Ju B; Wang J; Mo L; Huang J; Hao Z; Lv X; Pu D; He L
    Int Immunopharmacol; 2022 Jan; 102():108403. PubMed ID: 34857478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role and clinical significance of programmed cell death- ligand 1 expressed on CD19
    Jia XY; Zhu QQ; Wang YY; Lu Y; Li ZJ; Li BQ; Tang J; Wang HT; Song CW; Xie CH; Chen LJ
    Clin Immunol; 2019 Jan; 198():89-99. PubMed ID: 30502542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Syk phosphorylation leads to overexpression of TRAF6 in peripheral B cells of patients with systemic lupus erythematosus.
    Iwata S; Yamaoka K; Niiro H; Jabbarzadeh-Tabrizi S; Wang SP; Kondo M; Yoshikawa M; Akashi K; Tanaka Y
    Lupus; 2015 Jun; 24(7):695-704. PubMed ID: 25432781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diminished expression of complement regulatory proteins (CD55 and CD59) in lymphocytes from systemic lupus erythematosus patients with lymphopenia.
    García-Valladares I; Atisha-Fregoso Y; Richaud-Patin Y; Jakez-Ocampo J; Soto-Vega E; Elías-López D; Carrillo-Maravilla E; Cabiedes J; Ruiz-Argüelles A; Llorente L
    Lupus; 2006; 15(9):600-5. PubMed ID: 17080916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of complement activation products in Chinese patients with systemic lupus erythematosus.
    Li J; An L; Zhang Z
    Clin Exp Rheumatol; 2014; 32(1):48-53. PubMed ID: 23981509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of transcription factor Blimp1 in systemic lupus erythematosus.
    Luo J; Niu X; Liu H; Zhang M; Chen M; Deng S
    Mol Immunol; 2013 Dec; 56(4):574-82. PubMed ID: 23911415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CD19/CD81 complex physically interacts with CD38 but is not required to induce proliferation in mouse B lymphocytes.
    Vences-Catalán F; Rajapaksa R; Levy S; Santos-Argumedo L
    Immunology; 2012 Sep; 137(1):48-55. PubMed ID: 22564057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosus.
    Jacobi AM; Odendahl M; Reiter K; Bruns A; Burmester GR; Radbruch A; Valet G; Lipsky PE; Dörner T
    Arthritis Rheum; 2003 May; 48(5):1332-42. PubMed ID: 12746906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-21 is increased in active systemic lupus erythematosus patients and contributes to the generation of plasma B cells.
    Nakou M; Papadimitraki ED; Fanouriakis A; Bertsias GK; Choulaki C; Goulidaki N; Sidiropoulos P; Boumpas DT
    Clin Exp Rheumatol; 2013; 31(2):172-9. PubMed ID: 23137515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of CD19+CD24highCD38high B cells, IL‑10 and IL‑10R in peripheral blood from patients with systemic lupus erythematosus.
    Wang T; Li Z; Li X; Chen L; Zhao H; Jiang C; Song L
    Mol Med Rep; 2017 Nov; 16(5):6326-6333. PubMed ID: 28901380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tetraspanin CD81 regulates the expression of CD19 during B cell development in a postendoplasmic reticulum compartment.
    Shoham T; Rajapaksa R; Boucheix C; Rubinstein E; Poe JC; Tedder TF; Levy S
    J Immunol; 2003 Oct; 171(8):4062-72. PubMed ID: 14530327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral circulating activated b-cell populations are associated with nephritis and disease activity in patients with systemic lupus erythematosus.
    Dolff S; Wilde B; Patschan S; Dürig J; Specker C; Philipp T; Kribben A; Witzke O
    Scand J Immunol; 2007 Nov; 66(5):584-90. PubMed ID: 17868260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral B cell abnormalities in patients with systemic lupus erythematosus in quiescent phase: decreased memory B cells and membrane CD19 expression.
    Korganow AS; Knapp AM; Nehme-Schuster H; Soulas-Sprauel P; Poindron V; Pasquali JL; Martin T
    J Autoimmun; 2010 Jun; 34(4):426-34. PubMed ID: 19963348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.